side effects of semaglutide and tirzepatide Comparative safety and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide vs. Tirzepatide for Weight

[new 2015] Only continue GLP1 mimetic therapy if the person with type 2 diabetes has had a beneficial metabolic response (a reduction of at least 11 mmol/mol [1.0%] in HbA1c and a weight loss of at least 3% of initial body weight in 6 months)

LillyDirect pricing

instead, they state patients should discuss with their primary care physician and/or endocrinologist whether GLP-1 drug use should be ceased so that the risk of vision loss from NAION in their fellow eye is balanced with the hypoglycemic and cardiovascular benefits from treatment

Xiang J, et al

Eleven healthy volunteers had their blood sugar levels tested after drinking about 1 1/4 cups of either light roast or dark roast coffee